77 related articles for article (PubMed ID: 9796699)
1. NF1 inactivation cooperates with N-ras in in vivo lymphogenesis activating Erk by a mechanism independent of its Ras-GTPase accelerating activity.
Mangues R; Corral T; Lu S; Symmans WF; Liu L; Pellicer A
Oncogene; 1998 Oct; 17(13):1705-16. PubMed ID: 9796699
[TBL] [Abstract][Full Text] [Related]
2. An overexpressed N-ras proto-oncogene cooperates with N-methylnitrosourea in mouse mammary carcinogenesis.
Mangues R; Kahn JM; Seidman I; Pellicer A
Cancer Res; 1994 Dec; 54(24):6395-401. PubMed ID: 7987834
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice.
Mangues R; Corral T; Kohl NE; Symmans WF; Lu S; Malumbres M; Gibbs JB; Oliff A; Pellicer A
Cancer Res; 1998 Mar; 58(6):1253-9. PubMed ID: 9515813
[TBL] [Abstract][Full Text] [Related]
4. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
5. Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling.
Villalonga P; López-Alcalá C; Bosch M; Chiloeches A; Rocamora N; Gil J; Marais R; Marshall CJ; Bachs O; Agell N
Mol Cell Biol; 2001 Nov; 21(21):7345-54. PubMed ID: 11585916
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
7. Activated N-ras oncogene and N-ras proto-oncogene act through the same pathway for in vivo tumorigenesis.
Mangues R; Symmans WF; Lu S; Schwartz S; Pellicer A
Oncogene; 1996 Sep; 13(5):1053-63. PubMed ID: 8806695
[TBL] [Abstract][Full Text] [Related]
8. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
Xiao L; Lang W
Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
[TBL] [Abstract][Full Text] [Related]
9. NF1 regulates a Ras-dependent vascular smooth muscle proliferative injury response.
Xu J; Ismat FA; Wang T; Yang J; Epstein JA
Circulation; 2007 Nov; 116(19):2148-56. PubMed ID: 17967772
[TBL] [Abstract][Full Text] [Related]
10. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.
Kim HA; Rosenbaum T; Marchionni MA; Ratner N; DeClue JE
Oncogene; 1995 Jul; 11(2):325-35. PubMed ID: 7624147
[TBL] [Abstract][Full Text] [Related]
11. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
12. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice.
Tsutsumi T; Suzuki T; Moriya K; Shintani Y; Fujie H; Miyoshi H; Matsuura Y; Koike K; Miyamura T
Hepatology; 2003 Oct; 38(4):820-8. PubMed ID: 14512869
[TBL] [Abstract][Full Text] [Related]
14. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.
Dasgupta B; Li W; Perry A; Gutmann DH
Cancer Res; 2005 Jan; 65(1):236-45. PubMed ID: 15665300
[TBL] [Abstract][Full Text] [Related]
15. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
[TBL] [Abstract][Full Text] [Related]
16. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
17. Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype.
King D; Yang G; Thompson MA; Hiebert SW
Oncogene; 2002 Jul; 21(32):4978-82. PubMed ID: 12118376
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Ras effector mutant interactions with the NF1-GAP related domain.
Marshall MS; Hettich LA
Oncogene; 1993 Feb; 8(2):425-31. PubMed ID: 8426748
[TBL] [Abstract][Full Text] [Related]
19. Role of GTPases and GTPase regulatory proteins in oncogenesis.
Grunicke HH; Maly K
Crit Rev Oncog; 1993; 4(4):389-402. PubMed ID: 8353139
[TBL] [Abstract][Full Text] [Related]
20. NF1 modulates the effects of Ras oncogenes: evidence of other NF1 function besides its GAP activity.
Corral T; Jiménez M; Hernández-Muñoz I; Pérez de Castro I; Pellicer A
J Cell Physiol; 2003 Nov; 197(2):214-24. PubMed ID: 14502561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]